Overview

Role of Antibiotics in Preventing Infection in Babies Born Through Meconium Stained Liquor

Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of the study is to evaluate the role of antibiotics in preventing infection in babies born through meconium stained amniotic fluid. Normally babies do not pass meconium while in utero. In response to hypoxic stress babies may pass meconium before birth and are likely to be candidates for problems related to meconium passage and its inhalation. It is believed that these babies are more prone to infections as meconium enhances bacterial growth and may predispose such babies to secondary bacterial infections. In addition, meconium passage has been incriminated as a pointer of in-utero infection. Whether use of antibiotics in babies born through meconium stained amniotic fluid will reduce the infectious episodes and complications thereof or not is not clear. Moreover, there is not much published literature to prove or refute the same. Most clinicians have a low threshold for using antibiotics in such babies. In view of the uncertainty regarding antibiotic usage in these babies, the investigators decided to investigate the role of prophylactic antibiotics in prevention of neonatal sepsis in babies born through meconium stained amniotic fluid.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Lady Hardinge Medical College
Treatments:
Amikacin
Anti-Bacterial Agents
Antibiotics, Antitubercular
Penicillanic Acid
Piperacillin
Piperacillin, Tazobactam Drug Combination
Tazobactam
Criteria
Inclusion Criteria:

- Gestation > 37 weeks

- Meconium staining of amniotic fluid

- Cephalic presentation

- Singleton pregnancy

Exclusion Criteria:

- Major Congenital malformation

- Refusal of consent